Public company
Pyxis Oncology, Inc.
PYXSCIK 0001782223
Price$1.66
1 year-57.5%
Disclosed transactions1
Buys / sells0 / 0
Max Insider Score9
Connections with evidence3
PYXS · disclosed activity on price
Disclosed transactions
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Humphrey RachelDirector | PYXSPyxis Oncology, Inc. Grant or award | A | — 34.5K sh | Nov 6, 2026 |
Verified connections
- In industryevidencePharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 6, 2026
- ← Insider ofevidenceHumphrey RachelDirector · Nov 6, 2026
- ← Holds over 5% ofevidenceLaurion Capital Management LP5.16% of class · Schedule 13G · Nov 2, 2026